Schedule 13D ownership disclosure

BIOMEA FUSION INC

Common Stock · CUSIP: 09077A106

Event date: 2025-10-22

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Cormorant Global Healthcare Master Fund, LPReported CIK 0001618442

    Shares: 477,791 · Class: 0.69%

  • Cormorant Global Healthcare GP, LLCReported CIK 0001618451

    Shares: 477,791 · Class: 0.69%

  • Cormorant Private Healthcare Fund III LPReported CIK 0001817320

    Shares: 456,855 · Class: 0.66%

  • Cormorant Private Healthcare GP III, LLC

    Shares: 456,855 · Class: 0.66%

  • Cormorant Asset Management, LPReported CIK 0001583977

    Shares: 950,000 · Class: 1.37%

  • Chen BihuaReported CIK 0001599214

    Shares: 1,060,792 · Class: 1.53%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-003999
Form type
SCHEDULE 13D/A
Filer
Biomea Fusion, Inc.
CIK
CIK 1840439
Filed
Oct 24, 2025
Reporting period
Oct 22, 2025
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub